Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,227 public trials 1,019 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

Study of Intermittent OSI-906 Dosing

NCT00514306

Conditions
Adnexal Diseases, Advanced Solid Tumors, Breast Diseases, +43 more
Locations
  • MD Anderson Cancer Center Houston, Texas, United States
  • Drug Development Unit, Royal Marsden Hospital Sutton, Surrey, United Kingdom
View Trial Details
Completed

Efficacy Study of Nivolumab Compared to Docetaxel in Subjects Previously Treated With Advanced or Metastatic Non Small Cell Lung Cancer

NCT02613507

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Local Institution - 0051 Beijing, Beijing Municipality, China
  • Local Institution - 0007 Beijing, Beijing Municipality, China
  • Local Institution - 0032 Beijing, Beijing Municipality, China
  • Local Institution - 0026 Beijing, Beijing Municipality, China
View all 33 locations
View Trial Details
Completed

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

NCT03761914

Conditions
Acute Myelogenous Leukemia, Adnexal Diseases, Breast Diseases, +45 more
Locations
  • St. Joseph Heritage Healthcare Santa Rosa, California, United States
  • Innovative Clinical Research Institute (ICRI) Whittier, California, United States
  • Miami Cancer Institute at Baptist Health, Inc. Miami, Florida, United States
  • Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
View Trial Details
Completed

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

NCT02635672

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +65 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • Maryland Oncology Hematology Silver Spring, Maryland, United States
  • John Theurer Cancer Center Hackensack, New Jersey, United States
View all 16 locations
View Trial Details
Completed

A Dose Escalation Study of ASP8273 in Subjects With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations

NCT02113813

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Site US10010 Washington D.C., District of Columbia, United States
  • Site US10006 Baltimore, Maryland, United States
  • Site US10012 Boston, Massachusetts, United States
  • Site US10001 Boston, Massachusetts, United States
View Trial Details
Completed

Small Cell Lung Carcinoma Trial With Nivolumab and IpiliMUmab in LImited Disease

NCT02046733

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Diabetes Mellitus, Insulin-Dependent, 12, +10 more
Locations
  • Bendigo Hospital Bendigo, Australia
  • Coffs Harbour Health Campus Coffs Harbour, Australia
  • Royal Brisbane and Women's Hospital (QLD) Herston, Australia
  • Royal Hobart Hospital Hobart, Australia
View all 61 locations
View Trial Details
Completed

TEIPP Immunotherapy in Patients With NSCLC

NCT05898763

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Leiden University Medical Center Leiden, South Holland, Netherlands
  • Erasmus Medical Center Rotterdam, South Holland, Netherlands
View Trial Details

Related conditions